-
1.发明公开METHOD FOR SELECTION OF HDIS3 PIN DOMAIN INHIBITORS AND USE OF HDIS3 PIN DOMAIN INHIBITORS FOR CANCER TREATMENT 有权HDIS3 PIN结构域抑制剂的选择及HDIS3 PIN域抑制剂为癌症治疗
公开(公告)号：EP2999789A1
公开(公告)日：2016-03-30
申请号：EP14733705.9
申请日：2014-05-20
申请人： Instytut Biochemii I Biofizyki Polskiej Akademii Nauk , ONCOARENDI THERAPEUTICS SP. Z.O.O. , Miedzynarodowy Instytut Biologii Molekularnej I Komorkowej
发明人： DZIEMBOWSKI, Andrzej , TOMECKI, Rafal , DRAZKOWSKA, Karolina , SZCZESNY, Roman , STODUS, Krystian , JONKO, Weronika , NOWOTNY, Marcin , GOLEBIOWSKI, Adam , OLCZAK, Jacek
IPC分类号： C12N15/81
CPC分类号： C12Q1/6897 , A61K31/472 , C12N15/81 , C12Q1/18 , G01N33/5008 , G01N33/5011 , G01N33/5038 , G01N33/573 , G01N2333/916 , G01N2333/922 , G01N2500/04 , G01N2500/10
摘要： The present invention relates to a method for selection or screening of hDIS3 PIN domain inhibitors, yeast strain and cell line used in such methods It also relates to new therapeutic agents selected hDIS3 PIN domain inhibitors and uses thereof in the treatment of cancers having mutations inhDIS3 RNB domain, especially multiple myeloma. The invention also relates to composition comprising new therapeutic agent hDIS3 PIN domain inhibitor and method for inducing synthetic lethality in a cancer cell.
-
2.发明公开DERIVATIVES OF 1-(SUBSTITUTED SULFONYL)-2-AMINOIMIDAZOLINE AS ANTITUMOR AND ANTIPROLIFERATIVE AGENTS 审中-公开1-（取代的磺酰基）衍生物-2- AMINOIMIDAZOLIN ALS抗肿瘤和抗增殖剂
公开(公告)号：EP2875017A1
公开(公告)日：2015-05-27
申请号：EP14719203.3
申请日：2014-03-27
IPC分类号： C07D401/14 , C07D405/14 , C07D403/04 , C07D403/14 , C07D409/14 , A61K31/4168 , A61P35/00
CPC分类号： A61K31/4168 , A61K31/4178 , A61K31/4439 , A61K31/454 , A61K31/4709 , A61K31/506 , A61K45/06 , C07C247/06 , C07D401/14 , C07D403/04 , C07D403/12 , C07D403/14 , C07D405/14 , C07D409/14
摘要： The invention provides novel, water-soluble 2-aminoimidazoline derivatives having general Formula (I) as well as some precursors of Formula (I), which are very potent inducers of G2/M cell cycle arrest. In treated tumor cells, compounds of Formula (I) give gene expression profile distinct from known antimitotic agents. The invention also provides methods for preparing the compounds, and methods of using the compounds for the treatment of cancer or other mammalian diseases characterized by undesirably high levels of cell proliferation. The compounds of the invention are also expected to have utility as research tools.
-
3.发明授权METHOD FOR SELECTION OF HDIS3 PIN DOMAIN INHIBITORS AND USE OF HDIS3 PIN DOMAIN INHIBITORS FOR CANCER TREATMENT 有权HDIS3 PIN结构域抑制剂的选择及HDIS3 PIN域抑制剂为癌症治疗
公开(公告)号：EP2999789B1
公开(公告)日：2017-05-10
申请号：EP14733705.9
申请日：2014-05-20
申请人： Instytut Biochemii I Biofizyki Polskiej Akademii Nauk , ONCOARENDI THERAPEUTICS SP. Z.O.O. , Miedzynarodowy Instytut Biologii Molekularnej I Komorkowej
发明人： DZIEMBOWSKI, Andrzej , TOMECKI, Rafal , DRAZKOWSKA, Karolina , SZCZESNY, Roman , STODUS, Krystian , JONKO, Weronika , NOWOTNY, Marcin , GOLEBIOWSKI, Adam , OLCZAK, Jacek
IPC分类号： C12N15/81
CPC分类号： C12Q1/6897 , A61K31/472 , C12N15/81 , C12Q1/18 , G01N33/5008 , G01N33/5011 , G01N33/5038 , G01N33/573 , G01N2333/916 , G01N2333/922 , G01N2500/04 , G01N2500/10
-
-
搜索结果
3 条记录 (耗时 0.011 秒)
